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analysis is required to evaluate the appropriateness of FFF in 
lung SBRT. 
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Purpose or Objective: An electromagnetic (ELM) system 
(Calypso, Varian Medical System, Palo Alto, CA, USA) based 
on sub-millimeter high frequency localization of three 
transponders permanently implanted in the prostate, was 
recently introduced for continuous real-time tracking of the 
tumor. Several studies of the tracks acquired over thousands 
of patients were reported in literature and allowed to give a 
detailed insight of intra-fraction prostate motion. Aim of this 
work was to develop and validate a tool to selectively filter 
the signal produced by the ELM transponders and to apply it 
for the evaluation of the amplitude of prostate motion only 
due to patient’s breathing. 
 
Material and Methods: To selectively filter the signal 
produced by ELM transponders a software was developed in 
the Matlab environment (version R2014b). Briefly, the 
developed software computes the power density spectrum 
(PDS) of the recorded tracks and isolates the ‘breathing 
peak’, i.e. the peak which is centered at the frequency 
corresponding to the breathing average frequency of each 
single analyzed session. A bandpass filter on the breathing 
peak is then applied to the original tracking data, in order to 
isolate the motion of the prostate due to the breathing of the 
patient. The software was validated with data recorded with 
QUASAR moving phantom, provided with an home-made 
insert of three transponders. Simulated breathing frequencies 
of 10, 12, 14, 16, 18, 20, 22 and 24 cycles per minute were 
recorded for at least one minute with the ELM system. After 
validation, tracks of 6 prostate patients who underwent EBRT 
were analyzed for a total of 180 treatments sessions. For 
each session, the corresponding maximum amplitude of 
prostate motion along the three main directions was 
obtained. Intra patients average data and standard deviations 
were reported along with the overall maximum amplitude. 
 
Results: For the in-phantom validation, the developed 
software automatically computed the correct cycles per 
minute within a 0.52% uncertainty. The average amplitudes 
of prostate motion due to patient’s breathing are listed in 
Table 1. As expected, the smallest motion resulted in left-
right direction. The limited standard deviations indicate a 
low intra-patient motion variability. For each patient, the 
overall maximum amplitude turned out to be not negligible, 
but at the same time less than 0.5 mm. 
 
Conclusion: A tool to quantify prostate motion due to 
patient’s breathing was successfully developed, validated and 
applied to a consistent number of treatments sessions. 
Although small compared to the motion caused by the 
modifications of near organs (i.e. bladder and rectum), the 
achieved results show that the motion associated to patient’s 
breathing should be carefully considered in the definition of 
an adequate Internal Target Volume. 
This work was partially funded by Associazione Italiana per la 
Ricerca sul Cancro AIRC (grant N-14300)  
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Purpose or Objective: In proton therapy treatments of 
intraocular tumors, patients actively participate by fixating a 
red diode, prepositioned according to planning prescriptions, 
to stabilize gaze direction. This work aims to evaluate safety 
margins effectiveness against involuntary eye movement that 
may occur in the course of the treatment. 
 
Material and Methods: A custom eye tracking system (ETS), 
able to monitor eye position and orientation through 3D 
video-oculography techniques, was installed in a proton 
therapy (PT) treatment room (fig.1). All ocular PT centers 
are equipped with an in-room orthogonal X-ray imaging 
system used to verify treatment geometry. Tantalum radio-
opaque markers, sutured to the sclera of the diseased eye, 
aid to determine the gaze angle of the eye during simulation, 
and the correct eye position at treatment. During simulation, 
the ETS monitored the eye simultaneously with X-ray 
acquisition to assess the tantalum markers pose relative to 
eye position and orientation. As a result, the ETS was able to 
assess eye motion and markers position in physical 
coordinates during dose delivery. 
A first analysis was performed on two patients with three and 
two monitored treatment fraction respectively. Both patients 
had four implanted markers. To enable 3D localization of 
markers identified in X-ray images, the geometry of the 
imaging system was calibrated by means of the Direct Linear 
Transform (DLT) algorithm. We measured the distance 
between markers 3D position seen by the ETS during 
irradiation and identified on setup verification X-ray images 
acquired prior dose delivery to quantify intra-fraction eye 
motion. Margins expansions of 2.5 mm were applied laterally 
and distally. Median, interquartile range (IQR) and maximum 
values for the clip-to-clip distance are reported in table 1.  
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Results: The mean retro-projection error (± SD) for the DLT 
calibration of the X-ray system was 0.06±0.03 mm. Median 
values of markers deviation during irradiation, considering 
both patients, ranged between -0.54 mm/0.75 mm, -1.06 
mm/0.85 mm and -0.55 mm/0.90 mm in the LL (latero-
lateral), SI (superior-inferior) and AP (antero-posterior) 
direction, respectively. 
 
 
 
Conclusion: We documented eye motion well below the 
applied safety margins. Future activities will focus on 
quantifying the effect of intrafraction eye motion on dose 
deposition. 
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Purpose or Objective: In the present study we compare 
three different treatment-delivery techniques in terms of 
treatment time (TT) and its relation with intrafraction 
variation (IFV). Besides that, we analyzed different clinical 
factors that could influence on the IFV. Finally we 
appreciated the soundness of our margins. 
 
Material and Methods: Patients diagnosed of stage I lung 
cancer and lung metastases up to 5cm treated with SBRT in 
our centre were included in this study. All patients went 
through a 4DCT scan to create an internal target volume (ITV) 
and a 5mm margin was added to it to create a PTV. Each 
patient had a pretreatment Cone Beam CT (CBCT) and a 
postreatment CBCT. We compared the CBCTs with their 
reference 4D-CT to quantify the translational tumor shifts as 
well as the 3D composite vector. For our patients three 
different treatment-delivery techniques were employed: 
fixed fields (FF), arcs dynamically collimated (AA) or a 
combination of both (FA). We studied if TT was different 
among these ways of treatment and we search if there were 
any correlation between TT and IFV. We analyzed the 
influence of patients´ clinical characteristics (age, sex, 
performance status, pulmonary function, treatment time) 
and tumours´characteristics (location, nature, size) on IFV. 
 
Results: A total of 45 patients with 52 lesions were studied 
from which 147 fractions could be analyzed. Mean IFV for x, y 
and z axis were 1 ± 1.16mm, 1.29 ± 1.38mm and 1.17 ± 
1.08mm, respectively. 96.1% of the displacements were 
encompassed by the 5mm margin given. TT was significantly 
longer in FF therapy (24.76±5.4 min), when compare with AA 
(15.30±3.68 min) or FA (17.79±3.52 min) (p<0.001). Despite 
that, IFV did not change significantly between the three 
groups (p=0.471). Age (p=0.003) and left vs. right location 
(p=0.005) were related with 3D shift ≥ 2mm. The multivariate 
analysis showed that only age significantly influenced on IFV 
(OR=1.07, p=0.007). 
 
Conclusion: The election of AA, FF or FA does not impact in 
the IFV although FF treatments take significantly more time. 
Our 5 mm margin can be considered acceptable as it 
accounts for more than 95% of tumor shifts. Age is the only 
clinical factor that influence significantly on the IFV in our 
analysis.  
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Purpose or Objective: Clinical data suggest that every 1 Gy 
of the mean dose to the heart increases the risk of major 
coronary events by approximately 3% and the risk of coronary 
arteries damage by approximately 7%. The literature data 
show that the radiation dose delivered to the heart can be 
reduced by applying the Deep Inspiration Breath Hold (DIBH) 
technique. The aim of this study was to evaluate dose 
delivered to the heart and coronary arteries for a group of 
patients after breast conserving surgery (BCS) irradiated with 
3D-CRT-SIB (3D Conformal Radiotherapy Simultaneous-
Integrated Boost). 
 
Material and Methods: For 10 left-sided breast cancer 
patients, computed tomography-based treatment planning 
were performed at FB (Free Breathing) and DIBH mode. The 
CTV (Clinical Target Volume) covering the whole left breast 
and the post-lumpectomy tumor bed (boost). Important 
organs at risk (heart, territory of coronary arteries and lungs) 
were delineated. To form the PTV (Planning Target Volume) 
from CTV, the margin of 6 mm was added. For both DIBH and 
FB, treatment plans were prepared by medical physicist. The 
prescribed doses were 54Gy (2.7Gy/fraction) to PTV boost 
and 45Gy (2.25 Gy/fraction) to PTV breast. The mean dose 
